Botanical drug, Fulyzaq receives FDA approval to treat diarrhea in HIV/AIDS patients on antiretroviral therapy

The US Food and Drug Administration (FDA) announced today the approval of Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used More...